Document:

EX-10.1

 Exhibit 10.1 

EMPLOYMENT AGREEMENT 
 THIS
EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into this 10th day of January, 2019, by and between DORMAN PRODUCTS, INC., a Pennsylvania corporation (the “Company”), and KEVIN OLSEN (the
“Executive”), and is effective as of January 1, 2019 (the “Effective Date”). 
 W I T N E S S E T H:

 WHEREAS, the Company and the Executive desire to enter into this Agreement to set forth the terms and conditions of the Executive’s
continued employment with the Company as President and also, as of the Effective Date, Chief Executive Officer of the Company. 
 NOW,
THEREFORE, in consideration of the covenants and agreements hereinafter set forth and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

1.    EMPLOYMENT AND DUTIES 

1.1    Employment Period. The Company hereby agrees to continue to employ the Executive, and the Executive hereby
agrees to serve the Company, subject to the terms and conditions of this Agreement, for the period commencing on the Effective Date and ending on December 31, 2021, unless earlier terminated pursuant to Section 5 hereof (the
“Employment Period”, which shall include any renewals thereof); provided, that, on December 31, 2021 and each annual anniversary of such date thereafter (such date and each annual anniversary thereof, a
“Renewal Date”), unless previously terminated in accordance with the provisions of Section 5 hereof, the Employment Period shall be automatically extended so as to terminate one year from such Renewal Date unless, at least 120
days prior to the Renewal Date, either party shall give written notice to the other that the Employment Period shall not be so extended. 

1.2    General. 

1.2.1    During the Employment Period, the Executive shall have the title of President and Chief Executive Officer of the
Company and shall have the authorities, duties and responsibilities customarily exercised by an individual serving in these positions in a corporation of the size and nature of the Company and such other authorities, duties and responsibilities as
may from time to time be reasonably delegated to him by the Board of Directors of the Company (the “Board”) that are consistent with the foregoing. The Executive shall faithfully and diligently discharge his duties hereunder and use
his reasonable efforts to implement the policies established by the Board from time to time. The Executive shall report directly to the Board. 

1.2.2    The Executive shall devote all of his business time, attention, knowledge and skills faithfully, diligently and
to the best of his ability, in furtherance 

 
of the business and activities of the Company; provided, however, that nothing in this Agreement shall preclude the Executive from devoting reasonable periods of time required for: 

(i)    delivering lectures, fulfilling speaking engagements, and any writing or publication relating to his area of
expertise; provided, that any fees, royalties or honorariums received therefrom shall be promptly turned over to the Company; 

(ii)    engaging in professional organization and program activities; 

(iii)    managing his personal passive investments and affairs; and 

(iv)    participating in charitable or community affairs; 

provided that such activities do not materially, individually or in the aggregate, interfere with the due performance of his duties and responsibilities under
this Agreement or create a conflict of interest with the business of the Company, as determined in good faith by a majority of the non-employee members of the Board. Notwithstanding the foregoing, Executive
will be subject to any applicable restrictions set forth in the Company’s Corporate Governance Guidelines. 

1.3    Reimbursement of Expenses. During the Employment Period, the Company shall pay the reasonable expenses
incurred by the Executive in the performance of his duties hereunder, including, without limitation, those incurred in connection with business related travel or entertainment, or, if such expenses are paid directly by the Executive, the Company
shall promptly reimburse him for such payments, provided that the Executive properly accounts for such expenses in accordance with the Company’s business expense reimbursement policy. To the extent any such reimbursements (and any other
reimbursements of costs and expenses provided for herein) are includable in the Executive’s gross income for Federal income tax purposes, all such reimbursements shall be made no later than March 15 of the calendar year next following the
calendar year in which the expenses to be reimbursed are incurred. 
 2.    COMPENSATION 

2.1    Base Salary. During the Employment Period, the Executive shall be entitled to receive a base salary at a rate
of $600,000.00 per annum, which base salary shall be payable in accordance with the payroll practices of the Company, with such increases (but no decreases) as may be determined by the Compensation Committee from time to time (as increased from time
to time, the “Base Salary”). 
 2.2    Annual Bonuses. In addition to the Base Salary, the
Executive shall be eligible to receive during the Employment Period annual cash bonuses under the Company’s 2018 Cash Bonus Plan and/or any other cash incentive plan maintained by the Company, as determined by the Compensation Committee in its
sole discretion within the parameters of such plan(s). 
 2.3    Equity Related Awards. 

2.3.1    In connection with the execution of this Agreement, the Executive shall be granted an equity incentive award with
aggregate value equal to $1,000,000 (determined based on the closing price of the Company’s common stock as of the date such award is granted) under the Company’s 2018 Stock Option and Stock Incentive Plan. Fifty 

  
 2 

 
percent (50%) of such award shall be granted in the form of restricted stock units that vest in equal installments on each of the 3rd, 4th and 5th annual anniversaries of the grant date, provided the Executive remains in continuous employment with the Company through each such
vesting date. The remaining fifty percent (50%) of such equity award shall be granted in the form of restricted stock units that vest based on Company performance metrics to be established by the Compensation Committee at the time of grant and
consistent with the Company’s strategic plan. Such equity award shall be conditioned on the Executive’s execution of award agreements provided by the Company at the time of grant. 

2.3.2    Following the Effective Date, the Executive may receive during the Employment Period additional grants of awards
under the Company’s 2018 Stock Option and Stock Incentive Plan and/or any other equity-related incentive plan maintained by the Company, as determined by the Compensation Committee in its sole discretion within the parameters of such plan(s).

 2.3.3    The treatment of any equity awards held by the Executive under the 2018 Stock Option and Stock Incentive
Plan and/or any other equity-related incentive plan maintained by the Company in connection with the termination of the Executive’s employment shall be determined under such plan and/or award agreement relating to such award. 

2.4    Additional Compensation. During the Employment Period, in addition to the foregoing and the benefits and
perquisites described in Section 4, the Executive shall be eligible to receive such other compensation as may from time to time be awarded him by the Compensation Committee, in its sole discretion. 

2.5    Clawback. The Executive agrees that the compensation and benefits provided by the Company under this
Agreement or otherwise is subject to recoupment or clawback under any applicable Company clawback or recoupment policy that is generally applicable to the Company’s executives, as may be in effect from time to time, or as required by law,
government regulation or stock exchange listing requirement. 
 3.    PLACE OF PERFORMANCE. In connection with
his employment by the Company, the Executive shall be based at the Company’s executive offices, currently located in Colmar, Pennsylvania. 

4.    EMPLOYEE BENEFITS AND PERQUISITES 

4.1    Benefit Plans. During the Employment Period, the Executive shall be eligible to participate in all employee
benefit plans, programs or arrangements on the terms and conditions, including eligibility, no less favorable than provided to other senior executives of the Company, which shall be established or maintained by the Company generally for its
employees, or generally made available to its senior executives; provided, however, that participation in the Company’s 2018 Cash Bonus Plan, 2018 Stock Option and Stock Incentive Plan and/or other equity and incentive plans shall be as
determined by the Compensation Committee in its sole discretion, as described in Section 2. 

4.2    Vacation. The Executive shall be entitled to not less than four weeks’ vacation at full pay for each
calendar year during the Employment Period. Such vacation may be 

  
 3 

 
taken in the Executive’s discretion, and at such time or times as are not inconsistent with the reasonable business needs of the Company. Any vacation not used during a calendar year shall
be forfeited without compensation and may not be carried over to any subsequent calendar year. 
 4.3    Life
Insurance. The Company shall acquire and pay the applicable premium on a term life insurance policy on the life of the Executive with a benefit in the amount of $2,000,000 payable to a beneficiary designated by the Executive, provided that the
annual premium payable by the Company for such policy shall not exceed Ten Thousand Dollars ($10,000) (the “Life Premium Threshold”). To the extent the applicable annual premium would otherwise exceed the Life Premium
Threshold, at the Executive’s sole option, either (i) the benefit payable under the policy shall be reduced to the minimum extent necessary such that the annual premium for such policy does not exceed the Life Premium Threshold, or
(ii) the Executive shall reimburse the Company for the amount of the annual premium over the Life Premium Threshold. The Executive shall cooperate with the Company to the extent necessary to acquire such term life insurance policy, including
without limitation, by submitting to examinations by Company selected physicians. 
 4.4    Disability Insurance.
The Company shall acquire and pay the applicable premium on a long-term disability insurance policy for the Executive with a benefit in the amount of sixty percent (60%) of the Executive’s monthly earnings as of immediately prior to the
incurrence of the disability, provided that the annual premium payable by the Company for such policy shall not exceed Sixteen Thousand Five Hundred ($16,500) (the “Disability Premium Threshold”). To the extent the applicable
annual premium would otherwise exceed the Disability Premium Threshold, at the Executive’s sole option, either (i) the benefit payable under the policy shall be reduced to the minimum extent necessary such that the annual premium for such
policy does not exceed the Disability Premium Threshold, or (ii) the Executive shall reimburse the Company for the amount of the annual premium over the Disability Premium Threshold. The Executive shall cooperate with the Company to the extent
necessary to acquire such term long-term disability insurance policy, including without limitation, by submitting to examinations by Company selected physicians. 

5.    TERMINATION OF EMPLOYMENT PERIOD 

5.1    General. The Employment Period shall end as of the Executive’s termination of employment hereunder. The
Executive’s employment under this Agreement may be terminated without any breach of this Agreement only on the following circumstances: 

5.1.1    Death. The Executive’s employment under this Agreement shall terminate upon his death. 

5.1.2    Disability. If the Executive suffers a Disability (as defined below), the Company may terminate the
Executive’s employment under this Agreement upon ninety (90) days prior written notice; provided that the Executive has not returned to full time performance of his duties during such ninety (90) day period. For purposes hereof,
“Disability” shall mean the Executive’s “disability” under the Company’s long-term disability plan, if any, otherwise, the Executive’s inability to perform his duties and responsibilities hereunder, with or
without reasonable accommodation, due to any physical or mental illness or incapacity, which 

  
 4 

 
condition either (i) has continued for a period of 270 days (including weekends and holidays) in any consecutive 365-day period or (ii) is
projected by the Board in good faith in reliance upon the opinion of a physician mutually selected by the Company and Executive (or Executive’s authorized representative), that the condition is substantially likely to continue for a period of
at least nine (9) consecutive months from its commencement. 
 5.1.3    Good Reason. The Executive may
terminate his employment under this Agreement for Good Reason. For purposes of this Agreement, “Good Reason” shall mean the occurrence of any of the following events without the Executive’s consent: 

(i)    a material diminution of the title, authorities, duties or responsibilities of the Executive set forth in
Section 1.2 above; 
 (ii)    any reduction by the Company in the Executive’s Base Salary; 

(iii)    a change in the Executive’s primary place of employment such that the Executive’s commute increases by
at least twenty-five (25) miles; 
 (iv)    the assignment to the Executive of duties or responsibilities which
are materially inconsistent with any of his duties and responsibilities set forth in Section 1.2 hereof; 

(v)    a change in the reporting structure so that the Executive reports to someone other than solely and directly to the
Board; or 
 (vi)    the Company’s election to not renew this Agreement under Section 1.1; 

provided, however, that none of the foregoing events or conditions will constitute Good Reason unless the Executive provides the Company with written
objection to the event or condition within 90 days following the occurrence thereof, the Company does not reverse or otherwise cure the event or condition within 30 days of receiving that written objection, and the Executive resigns his employment
within 30 days following the expiration of that cure period. 
 5.1.4    Without Good Reason. The Executive may
voluntarily terminate his employment under this Agreement without Good Reason upon written notice by the Executive to the Board at least one hundred and twenty (120) days prior to the effective date of such termination. 

5.1.5    Cause. The Company may terminate the Executive’s employment under this Agreement at any time for
Cause. Termination for “Cause” shall mean termination of the Executive’s employment because of the occurrence of any of the following as determined by the Board: 

(i)    the willful and continued failure by the Executive to attempt in good faith substantially to perform his
obligations under this Agreement (other than 

  
 5 

 
any such failure resulting from the Executive’s incapacity due to a Disability); provided, however, that the Company shall have provided the Executive with written notice that such actions
are occurring and, where practical, the Executive has been afforded at least thirty (30) days to cure same; 

(ii)    the indictment of the Executive for, or his conviction of or plea of guilty or nolo contendere to, a felony or
any other crime involving moral turpitude or dishonesty; or 
 (iii)    the Executive’s willfully engaging in
misconduct in the performance of his duties for the Company or other than in the performance of his duties for the Company (including, but not limited to, theft, fraud, embezzlement, and securities law violations or a violation of the Company’s
”Values and Standards of Business Conduct” or other written policies) that is materially injurious to the Company, or, in the good faith determination of the Compensation Committee, is potentially materially injurious to the Company,
monetarily or otherwise. 
 For purposes of this Section 5.1.5, no act, or failure to act, on the part of the Executive shall be
considered “willful,” unless done, or omitted to be done, by him in bad faith and without reasonable belief that his action or omission was in, or not opposed to, the best interest of the Company (including reputationally). Prior to any
termination for Cause, the Executive will be given five (5) business days written notice specifying the alleged Cause event and will be entitled to appear (with counsel) before the Board to present information regarding his views on the Cause
event, and after such hearing, there is at least a majority vote of the Board to terminate him for Cause. After providing the notice in foregoing sentence, the Board may suspend the Executive with full pay and benefits until a final determination
pursuant to this Section has been made. 
 5.1.6    Without Cause. The Company may terminate the
Executive’s employment under this Agreement without Cause immediately upon written notice by the Company to the Executive, other than for death or Disability. 

5.2    Notice of Termination. Any termination of the Executive’s employment by the Company or by the Executive
(other than termination by reason of the Executive’s death) shall be communicated by written Notice of Termination to the other party of this Agreement. For purposes of this Agreement, a “Notice of Termination” shall mean a written
notice which shall indicate the specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under the
provision so indicated. 
 5.3    Date of Termination.    The “Date of
Termination” shall mean (a) if the Executive’s employment is terminated by his death, the date of his death; (b) if the Executive’s employment is terminated pursuant to Section 5.1.2, ninety (90) days after
Notice of Termination is given (provided that the Executive shall not have returned to the performance of his duties on a full-time basis during such ninety (90) day period); (c) if the Executive’s employment is terminated pursuant to
Sections 5.1.3 or 5.1.5, the date specified in the Notice of Termination after the expiration of any applicable cure periods; (d) if the Executive’s employment is 

  
 6 

 
terminated pursuant to Section 5.1.4, the date specified in the Notice of Termination which shall be at least one hundred and twenty (120) days, as applicable, after Notice of
Termination is given, or such earlier date as the Company shall determine, in its sole discretion; and (e) if the Executive’s employment is terminated pursuant to Section 5.1.6, the date specified in the Notice of Termination. 

5.4    Compensation Upon Termination. 

5.4.1    Termination for Cause or without Good Reason. If the Executive’s employment shall terminate under
Section 5.1.4 or Section 5.1.5, the Executive shall receive from the Company: (a) any earned but unpaid Base Salary through the Date of Termination, paid in accordance with the Company’s standard payroll practices;
(b) reimbursement for any unreimbursed expenses properly incurred and paid in accordance with Section 1.3 through the Date of Termination; (c) payment for any accrued but unused vacation time in accordance with Company policy;
(d) such vested accrued benefits, and other payments, if any, as to which the Executive (and his eligible dependents) may be entitled under, and in accordance with the terms and conditions of, the employee benefit arrangements, plans and
programs of the Company (including equity awards which pursuant to the terms of the 2018 Stock Option and Stock Incentive Plan and/or the applicable award agreement vest as of the Date of Termination) as of the Date of Termination, ((a) through
(d) herein referred to as the “Amounts and Benefits”); and the Company shall have no further obligation with respect to this Agreement, except as provided in Sections 7 and 8 of this Agreement. 

5.4.2    Termination for Good Reason or Without Cause. If the Executive’s employment terminates under
Sections 5.1.3 or 5.1.6, then the Company shall pay or provide the Executive the Amounts and Benefits and, subject to Section 5.4.4: 

(i)    the Executive’s Base Salary will continue to be paid for a period of eighteen (18) months following
termination of employment in accordance with the usual payroll practices of the Company; 
 (ii)    the Company shall
pay the Executive an amount equal to 150% of the Executive’s target annual bonus that was in effect at the time of Executive’s termination under the Company’s 2018 Cash Bonus Plan and/or any other cash incentive plan maintained by the
Company in a lump sum on the regular payroll date of the Company coincident with or next following the 60th day after the Executive’s date of employment termination; 

(iii)    the Company shall pay to the Executive an amount equal to a pro-rated
annual bonus (“Pro-Rated Annual Bonus”) for the year in which such employment termination occurs, which Pro-Rated Annual Bonus shall be determined (a) if
Executive’s employment terminates after September 30 of any year, by multiplying (i) the quotient obtained by dividing (A) the number of days the Executive worked in the year his employment with the Company terminates by (B) 365,
and (ii) an amount equal to the annual bonus (if any) that the Executive would have otherwise received under the Company’s 2018 Cash Bonus Plan and/or any other cash incentive plan maintained by the Company had he remained employed with
the Company with such amount to be calculated by the Board in its discretion in a similar manner as 

  
 7 

 
bonuses are calculated for other executives under the Company’s 2018 Cash Bonus Plan and/or any other cash incentive plan maintained by the Company, which such
Pro-Rated Annual Bonus shall be paid at the time the Executive’s annual bonus would have otherwise been paid absent the Executive’s termination of employment, but no later than March 15th of the year following termination or (b) if Executive’s employment terminates on or before September 30 of any year, by multiplying (i) the quotient obtained by dividing
(A) the number of days the Executive worked in the year his employment with the Company terminates by (b) 365, and (ii) Executive’s target annual bonus that was in effect at the time of Executive’s termination under the
Company’s 2018 Cash Bonus Plan and/or any other cash incentive plan maintained by the Company, which such Pro-Rated Annual Bonus shall be paid within sixty days following the Date of Termination; and 

(iv)    during the period during which Executive, his spouse and/or dependents are entitled to and validly elect
continuation coverage under COBRA or similar state law (provided that in no event will such period exceed 18 months), the Company shall pay to the Executive monthly cash payments in an amount equal to the monthly premium for such coverage for the
electing Executive, spouse and/or dependents. Such monthly amounts shall be paid on the first payroll date of each month. 

5.4.3    Termination upon Death or Disability. If the Executive’s employment terminates under Sections 5.1.1
or 5.1.2, then the Company shall pay or provide the Executive the Amounts and Benefits and continued Base Salary payments for a period of three (3) months following the Date of Termination in accordance with the usual payroll practices of the
Company. 
 5.4.4    No Mitigation or Offset. The Executive shall not be required to mitigate the amount of any
payment provided for in this Section 5.4 by seeking other employment or otherwise, and the amount of any payment provided for in this Section 5.4 shall not be reduced by any insurance benefits, compensation earned by the Executive as the
result of employment by another employer or business or by profits earned by the Executive from any other source at any time before and after the Date of Termination. The Company’s obligation to make any payment pursuant to, and otherwise to
perform its obligations under, this Agreement shall not be affected by any offset, counterclaim or other right that the Company may have against the Executive for any reason. 

5.4.5    Release. Notwithstanding any provision to the contrary in this Agreement, the Company’s obligation
to pay or to provide the Executive with the payments and benefits under Section 5.4.2 (other than the Amounts and Benefits), shall be conditioned on the Executive’s executing and not revoking a waiver and general release substantially in
the form set forth as Exhibit A attached to this Agreement (with such changes therein, if any, as are legally necessary at the time of execution to make it enforceable as reasonably determined by the Company) (the “Release”) by the 60th day following the effective date of his termination of employment. The benefits described in Section 5.4.2 will begin to be paid or provided as soon as administratively practicable after the
Release becomes irrevocable, provided that if the 60-day period described above begins in one taxable year and ends in a second taxable year such payments or benefits shall not commence until the second
taxable year. 

  
 8 

 6.    NEGATIVE COVENANTS OF THE EXECUTIVE. 

6.1    During the Employment Period and for a period of eighteen (18) months thereafter, the Executive will not,
directly or indirectly: 
 (i)    solicit, entice, persuade or induce any employee, director, officer, associate,
consultant, agent or independent contractor of the Company and its subsidiaries and affiliates (collectively, the “Company Group”) to terminate his or her employment or engagement by the Company Group in order to become employed or
engaged by any person, firm, corporation or other business enterprise other than a member of the Company Group, except in furtherance of his responsibility during the Employment Period; or 

(ii)    authorize or assist in the taking of such action by any third party. 

For purposes of this Section 6.1, the terms “employee,” “director,” “officer,” “associate,”
“consultant,” “agent,” and “independent contractor” shall include any person with such status at any time during the twelve (12) months prior to the termination of the Executive’s employment and for eighteen
(18) months following the Executive’s termination of employment. The Executive shall not be deemed to have violated the provisions of this Section 6.1 by reason of an isolated act, or failure to act, not taken in bad faith. 

6.2    During the Employment Period and for a period of eighteen (18) months thereafter, the Executive will not,
directly or indirectly, engage, participate, make any financial investment in, or become employed by or render advisory or other services to or for any person, firm, corporation or other business enterprise (together with its affiliates and
subsidiaries, the “Competing Enterprise”) which is engaged, directly or indirectly, during the Employment Period in competition with the Company Group as a supplier of automotive replacement parts, brake parts and fasteners to the
automotive aftermarket (including, without limitation, the light, medium, and heavy duty truck aftermarket) or as a supplier of home fasteners and electrical wiring components to mass merchandisers, or in any other business activities of the Company
Group accounting for more than 10% of its gross sales in the most recently completed fiscal year or reasonably expected to do so in the current fiscal year, in the United States and in any foreign jurisdiction in which the Company Group operates or,
at the end of Employment Period, proposes to operate; provided, in either case, that the competitive businesses of the Competing Enterprise account for more than 10% of the gross sales of the Competing Enterprise for its most recently completed
fiscal year and the Executive does not work or consult in such competitive business. The foregoing covenant shall not be construed to preclude the Executive from making any investments in the securities of any company, regardless of whether engaged
in competition with the Company Group, to the extent that such securities are actively traded on a national securities exchange or in the over-the-counter market in the
United States or any foreign securities exchange and, after giving effect to such investment, the Executive does not beneficially own securities representing more than 1% of the combined voting power of the voting securities of such company. 

6.3    During the Employment Period and thereafter without limit as to time, the Executive will not (other than in the
regular course and in furtherance of the Company Group’s 

  
 9 

 
business) use, divulge, furnish or make available to any person any knowledge or information with respect to the business or affairs of the Company Group which is confidential, including, without
limitation, “know-how,” trade secrets, customer and supplier lists, pricing policies, operational methods, marketing plans or strategies, product development techniques or plans, business acquisition
or disposition plans, new personnel employment plans, methods of manufacture, technical processes, designs and design projects, inventions and research projects and financial budgets and forecasts of the Company Group except (1) information
which at the time is available to others in the business or generally known to the public other than as a result of disclosure by the Executive not permitted hereunder, and (2) when required to do so by a court of competent jurisdiction, by any
governmental agency or by any administrative body or legislative body (including a committee thereof) with purported or apparent jurisdiction to order the Executive to divulge, disclose or make accessible such information. All memoranda, notes,
lists, records, electronically stored data, recordings or videotapes and other documents (and all copies thereof) made or compiled by the Executive or made available to the Executive (whether during his employment by the Company Group or by any
predecessor thereof) concerning the business of the Company Group or any predecessor thereof shall be the property of the Company or such other member of the Company Group and shall be delivered to the Company or such other member of the Company
Group promptly upon the termination of the Employment Period. Notwithstanding the foregoing, nothing contained in this Agreement limits the Executive’s ability to file a charge or complaint with the Securities and Exchange Commission (the
“SEC”) and this Agreement does not limit Executive’s ability to communicate with the SEC or otherwise participate in any investigation or proceeding that may be conducted by the SEC, including providing documents or other information.

 6.4    The Executive acknowledges that all developments, including, without limitation, inventions, patentable or
otherwise, trade secrets, discoveries, improvements, ideas, writings and works for hire that alone or jointly with others the Executive may conceive, make, develop or acquire during the period of his employment by the Company Group and any
predecessor thereof (collectively, the “Developments”), are and shall remain the sole and exclusive property of the Company Group; and the Executive hereby assigns to the Company Group all of his right, title and interest in all
such Developments. The Executive shall promptly and fully disclose all future Developments to the Board, and, at any time upon request and at the expense of the Company, shall execute, acknowledge and deliver to the Company Group all instruments
that the Company Group shall prepare, give evidence, and take all other actions that are necessary or desirable in the reasonable opinion of the Company’s counsel, to enable the Company Group to file and prosecute applications for and to
acquire, maintain and enforce all letters patent, trademark registrations or copyrights covering the Developments in all countries in which the same are deemed necessary. 

6.5    The Executive acknowledges that the services to be rendered by the Executive are of a special, unique and
extraordinary character and, in connection with such services, the Executive will have access to confidential information vital to the Company Group’s business and that irreparable injury would be sustained by the Company Group in the event of
his breach of any of the covenants contained in this Section 6, which injury could not be remedied adequately by the recovery of damages in an action at law. Accordingly, the Executive agrees that, upon a breach or threatened breach by him of
any of such covenants, the Company and, to the extent appropriate, any other member of the Company Group shall be entitled, in 

  
 10 

 
addition to and not in lieu of any and all other remedies, to an injunction to be issued by any court of competent jurisdiction restraining the commission or continuance of any such breach or
threatened breach upon minimal bond, with or without surety, and that such an injunction will not work an undue hardship on him. Without limiting the generality of the foregoing, if the Executive breaches of any of the covenants contained in this
Section 6, the Company may immediately cease paying, and the Executive shall have no further right to receive, any or all of the payments and benefits to which the Executive is otherwise entitled to receive under Section 5.4.2 other than
Amounts and Benefits which the Executive will be entitled to receive under Section 5.4.1. 
 6.6    The provisions
of this Section 6 shall survive the termination of this Agreement as set forth in each subsection, irrespective of the reasons therefor. 

6.7    If any court determines that any of the provisions of this Section 6 is invalid or unenforceable, the
remainder of such provisions shall not thereby be affected and shall be given full effect without regard to the invalid provisions. If any court construes any of the provisions of this Section 6, or any part thereof, to be unreasonable because
of the duration of such provision or the geographic scope thereof, such court shall have the power to reduce the duration or restrict the geographic scope of such provision and to enforce such provision as so reduced or restricted. 

7.    INDEMNIFICATION/ DIRECTORS AND OFFICERS LIABILITY INSURANCE 

During the Employment Period and thereafter, the Company shall indemnify and hold harmless the Executive and his heirs and representatives as,
and to the extent, provided in the Company’s charter documents, including, but not limited to, its By-Laws. During the Employment Period and thereafter, the Company shall also cover Executive under the
Company’s directors’ and officers’ liability insurance on the same basis as it covers other senior executive officers and directors of the Company. 

8.    MISCELLANEOUS 

8.1    Notices. All notices or communications hereunder shall be in writing, addressed as follows (or to such other
address as either party may have furnished to the other in writing by like notice): 
  

			
	 To the Company:    
	  	Dorman Products, Inc.
		  	 3400 East Walnut Street
 Colmar, PA 18915 –
Attn: General Counsel

 To the Executive, at the last address for the Executive on the books of the Company. 

Such addresses may be changed by notice by Company to the Executive or by notice by Executive to the Company. 

8.2    Severability. Each provision of this Agreement shall be interpreted in such manner as to be effective and
valid under applicable law, but if any provision of this 

  
 11 

 
Agreement is held to be prohibited by or invalid under applicable law, such provision will be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of
such provision or the remaining provisions of this Agreement. 
 8.3    Binding Effect; Benefits. Executive may
not delegate his duties or assign his rights hereunder. No rights or obligations of the Company under this Agreement may be assigned or transferred by the Company other than pursuant to a merger or consolidation in which the Company is not the
continuing entity, or a sale, liquidation or other disposition of all or substantially all of the assets of the Company, provided that the assignee or transferee is the successor to all or substantially all of the assets or businesses of the Company
and assumes the liabilities, obligations and duties of the Company under this Agreement, either contractually or by operation of law. For the purposes of this Agreement, the term “Company” shall include the Company and, subject to the
foregoing, any of its successors and assigns. This Agreement shall inure to the benefit of, and be binding upon, the parties hereto and their respective heirs, legal representatives, successors and permitted assigns. 

8.4    Entire Agreement. This Agreement, including the Exhibits hereto, represents the entire agreement of the
parties with respect to the subject matter hereof and shall supersede any and all previous contracts, arrangements or understandings between the Company and the Executive. This Agreement (including any of the Exhibits hereto) may be amended at any
time by mutual written agreement of the parties hereto. 
 8.5    Withholding. The payment of any amount pursuant
to this Agreement shall be subject to applicable withholding and payroll taxes, and such other deductions as may be required by applicable law. 

8.6    Governing Law. This Agreement and the performance of the parties hereunder shall be governed by the internal
laws (and not the law of conflicts) of the Commonwealth of Pennsylvania. 
 8.7    Arbitration. Any dispute or
controversy arising under or in connection with this Agreement shall be settled exclusively by arbitration conducted in Montgomery County, Pennsylvania under the Employment Arbitration Rules then prevailing of the American Arbitration Association
and such submission shall request the American Arbitration Association to: (i) appoint an arbitrator experienced and knowledgeable concerning the matter then in dispute; (ii) require the testimony to be transcribed; (iii) require the
award to be accompanied by findings of fact and a statement of reasons for the decision; and (iv) request the matter to be handled by and in accordance with the expedited procedures provided for in the Commercial Arbitration Rules. The
determination of the arbitrator(s), which shall be based upon a de novo interpretation of this Agreement, shall be final and binding and judgment may be entered on the arbitrators’ award in any court having jurisdiction. All costs of the
American Arbitration Association and the arbitrator shall be borne by the Company, unless the position advanced by the Executive is determined by the arbitrator to be frivolous in nature. EACH PARTY WAIVES THE RIGHT TO TRIAL BY JURY. 

  
 12 

 8.8    Tax Matters. 

8.8.1    It is intended that the provisions of this Agreement comply with Section 409A of Internal
Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder (collectively “Code Section 409A”), and all provisions of this Agreement shall be construed in a manner consistent with the
requirements for avoiding taxes or penalties under Code Section 409A. If any provision of this Agreement (or of any award of compensation, including equity compensation or benefits) would cause the Executive to incur any additional tax or
interest under Code Section 409A, the Company shall, upon the specific request of the Executive, use its reasonable business efforts to in good faith reform such provision to comply with Code Section 409A; provided that, to the maximum
extent practicable, the original intent and economic benefit to the Executive and the Company of the applicable provision shall be maintained, but the Company shall have no obligation to make any changes that could create any additional economic
cost or loss of benefit to the Company. The Company shall timely use its reasonable business efforts to amend any plan or program in which the Executive participates to bring it in compliance with Code Section 409A. Notwithstanding the
foregoing, the Company shall have no liability with regard to any failure to comply with Code Section 409A so long as it has acted in good faith with regard to compliance therewith. 

8.8.2    A termination of employment shall not be deemed to have occurred for purposes of any provision of
this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment unless such termination is also a “Separation from Service” within the meaning of Section 409A and, for purposes of any
such provision of this Agreement, references to a “termination,” “termination of employment” or like terms shall mean such Separation from Service. If the Executive is deemed on the date of termination of his employment to be a
“specified employee,” within the meaning of that term under Section 409A(a)(2)(B) of the Code and using the identification methodology selected by the Company from time to time, or if none, the default methodology, then with regard to
any payment, the providing of any benefit or any distribution of equity made subject to this Section 8.8.2, to the extent required to be delayed in compliance with Section 409A(a)(2)(B) of the Code, and any other payment, the provision of
any other benefit or any other distribution of equity that is required to be delayed in compliance with Section 409A(a)(2)(B) of the Code, such payment, benefit or distribution shall not be made or provided prior to the earlier of (i) the
expiration of the six-month period measured from the date of the Executive’s Separation from Service or (ii) the date of the Executive’s death. On the first day of the seventh month following
the date of Executive’s Separation from Service or, if earlier, on the date of his death, (x) all payments delayed pursuant to this Section 8.8.2 (whether they would have otherwise been payable in a single sum or in installments in
the absence of such delay) shall be paid or reimbursed to the Executive in a lump sum, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein
and (y) all distributions of equity delayed pursuant to this Section 8.8.2 shall be made to the Executive. On any delayed payment date under this Section 8.8.2, there shall be paid to the Executive or, if the Executive has died, to
his estate, in a single cash lump sum together with the payment of such delayed payment, interest on the aggregate amount of such delayed payment at the “Delayed Payment Interest Rate” (as defined below)

  
 13 

 
computed from the date on which such delayed payment otherwise would have been made to the Executive until the date paid. For purposes of the foregoing, the “Delayed Payment Interest
Rate” shall mean the short term Applicable Federal Rate as of the business day immediately preceding the payment date for the applicable delayed payment. For purposes of the application of Code Section 409A, each payment in a series of
payments under this Agreement will be deemed a separate payment. 
 8.8.3    With regard to any
provision herein that provides for reimbursement of costs and expenses or in-kind benefits, except as permitted by Code Section 409A: (i) the right to reimbursement or
in-kind benefits shall not be subject to liquidation or exchange for another benefit; (ii) the amount of expenses eligible for reimbursement, or in-kind benefits,
provided during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year, provided that the foregoing clause (ii) shall not
be violated with regard to expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the arrangement is in effect; and (iii) such payments
shall be made on or before the last day of the Executive’s taxable year following the taxable year in which the expense was incurred. 

8.9    Survivorship. Except as otherwise expressly set forth in this Agreement, upon the expiration of the
Employment Period, the respective rights and obligations of the parties shall survive such expiration to the extent necessary to carry out the intentions of the parties as embodied in this Agreement. This Agreement shall continue in effect until
there are no further rights or obligations of the parties outstanding hereunder and shall not be terminated by either party without the express prior written consent of both parties. 

8.10    Counterparts. This Agreement may be executed in counterparts (including by fax or pdf) which, when taken
together, shall constitute one and the same agreement of the parties. 
 8.11    Executive’s
Representations. The Executive acknowledges that before entering into this Agreement he has received a reasonable period of time to consider this Agreement and has had sufficient time and an opportunity to consult with any attorney or other
advisor of his choice in connection with this Agreement and all matters contained herein, and that he has been advised to do so if he so chooses. The Executive further acknowledges that this Agreement and all terms hereof are fair, reasonable and
are not the result of any fraud, duress, coercion, pressure or undue influence exercised by the Company, that he has approved and entered into this Agreement and all of the terms hereof on his own free will, and that no promises or representations
have been made to him by any person to induce him to enter into this Agreement other than the express terms set forth herein. 

8.12    Headings. Paragraph headings are included in this Agreement for convenience of reference only and shall not
affect the interpretation of the text hereof. 
 [End of Text - Signature page follows] 

  
 14 

 Intending to be legally bound hereby, the Company has caused this Agreement to be duly
executed and the Executive has hereunto set his hand, as of the Effective Date. 
  

					
	DORMAN PRODUCTS, INC.
		
	By:	 	 /s/ John J. Gavin

		 	Name:	 	John J. Gavin
		 	Title:	 	Director
	
	EXECUTIVE
	
	 /s/ Kevin M. Olsen

	Kevin Olsen

  
 15 

 EXHIBIT A 

General Release and Waiver 

Intending to be legally bound, and in consideration for Dorman Products, Inc. (the “Company”) providing me with payments and benefits
(subject to taxes and all withholding requirements) set forth in Section 5.4 of the Employment Agreement between Dorman Products, Inc. and me, dated December     , 2018 (the “Employment Agreement”), but not
including the Amounts and Benefits (as defined in such Employment Agreement), I, Kevin Olsen, on behalf of and for the benefit of myself, my heirs, executors, administrators, representatives, successors and assigns, agree to the following: 

 

	1)	 I fully, finally, and forever waive and release any and all claims that I have or may have against the Company,
its past, present, and future parents, subsidiaries, affiliates, related companies, successors, assigns, shareholders, officers, directors, agents, representatives, employees and insurers, and all persons acting by, through, under or in concert with
them, or any of them (collectively, the “Releasees”), based on any claim or cause of action arising at any time prior to and including the date that I sign this General Waiver and Release (this “Release”), provided that I do not
waive or release any claims for or relating to the Amounts and Benefits or any compensation upon termination of employment as set forth in Section 5.4 of the Employment Agreement (all such unreleased claims, the “Unreleased Claims”).

  

	2)	 I represent, warrant and covenant that I have not filed any complaints, charges or lawsuits against any
Releasees. I agree further that I will terminate with prejudice any and all pending legal actions, complaints, suits or charges that I have made or instituted against any and all Releasees based on any claim, matter or thing arising at any time
prior to and including the date Executive signs this Release. 

  

	3)	 I, on behalf of my heirs, executors, estate, administrators and assigns, hereby unconditionally and generally
releases and discharges Releasees, and each and every one of them, of and from all actions, causes of action in law or equity, claims, suits, debts, liens, contracts, agreements, promises, liability, damages, loss or expense, and demands of any
nature whatsoever, known or unknown, foreseen or unforeseen, fixed or contingent (hereinafter, collectively, “Claims”), which I have or may have against Releasees, and/or any of them, arising at any time prior to and including the date I
sign this Release; further including, without limitation, any and all Claims which relate directly or indirectly to my employment with the Company and my separation from that employment; and further including, without limitation, Claims related to
salary, bonuses, commissions, stock, stock options, or any other ownership or equity interest in the Company, vacation pay, fringe benefits, expense reimbursements, severance pay, or any other form of compensation; and further including, without
limitation, Claims, whether statutory, at common law or otherwise, for wrongful termination of employment, retaliation (including whistleblower Claims), breach of contract, detrimental reliance, promissory estoppel, infliction of emotional distress,
defamation, fraud, breach of covenant of good faith and fair dealing, misrepresentation or any other tort, and Claims under the laws of the United States, the Commonwealth of Pennsylvania, or any other state; and further including, without
limitation, Claims under the Family and Medical Leave Act, Employee Retirement Income Security Act, the Racketeer Influence and Corrupt 

	 	
Organizations Act, the Worker Adjustment and Retraining Notification Act, the Sarbanes-Oxley Act, or qui tam claims under the False Claims Act, or Claims for discrimination based upon sex, race,
age, national origin, religion, handicap, disability, or other protected status, or for retaliation, including, without limitation, Claims based on Title VII of the United States Civil Rights Act of 1964, Section 1981 of U.S.C. Title 42, the
Equal Pay Act, the United States Americans with Disabilities Act, the Genetic Information Nondiscrimination Act, the United States Age Discrimination in Employment Act, the Pennsylvania Human Relations Act; and any Claims under any other law, local,
state or federal, pertaining to employment or the relationship between employer and employee; provided, however, that this Release shall not apply to (a) any rights or Claims that are not waivable as a matter of law or (b) the Unreleased
Claims. 

  

	4)	 I represent, warrant and covenant that I have not heretofore assigned or transferred, or purported to assign or
transfer, to any person or entity, any Claims against any Releasee or any portion thereof or interest therein. 

  

	5)	 I hereby waive any right to become, and promise not to become, a member of any class or collective action
proceeding or case against the Company or any Releasee based on any Claim that arises prior to the date Executive signs this Release. 

  

	6)	 This Release shall not apply to my Claims for workers’ compensation or unemployment compensation benefits
or to any legal action seeking to challenge the validity of, or to enforce, this Release. 

  

	7)	 I understand and agree that nothing in this Release is intended to, or shall, interfere with or affect my right
to participate or cooperate in any federal, state, or local administrative or government agency (such as the Equal Employment Opportunity Commission, Securities and Exchange Commission, Department of Labor or National Labor Relations Board)
proceeding or investigation or to file a charge or claim with such an agency. I agree that I waive, and shall not be entitled to any recovery, relief, or monetary award in connection with any such charge, claim, or proceeding, regardless of who
filed or initiated the charge, claim, or proceeding (including, without limitation, any charge, claim, or proceeding filed or initiated by a government agency or other third party), except to the extent, if any, that such waiver is prohibited by
law. Notwithstanding the foregoing, this Release does not limit my right to receive an award for information provided to the Securities and Exchange Commission. 

 

	8)	 I intend for this Release to comply with the Older Workers’ Benefit Protection Action of 1990 (29 U.S.C.
Section 626), as amended. Accordingly, I acknowledge and represent as follows: 

  

	 	a)	 I waive any rights or Claims I may have, including but not limited to those under the United States Age
Discrimination in Employment Act (“ADEA”), knowingly and voluntarily and in exchange for the consideration of value to which Iwould not otherwise have been entitled, as set forth in the Agreement. 

 

	 	b)	 I have been advised by the Company to consult an attorney before I sign this Release. 

  
 2 

	 	c)	 I have been given a period of at least twenty-one (21) days within
which to consider this Release. I understand and acknowledge that, at my option alone, this Release may be executed prior to the expiration of the twenty-one (21) day period. 

 

	 	d)	 I have been informed by the Company that I may revoke this Release during a period of seven (7) days after
signing it by providing written notice of such revocation to Dorman Products, Inc. – Attention: Vice President, Human Resources, 3400 East Walnut Street, Colmar, PA 18915, which is received prior to the end of the seven (7) day period and
that this Release shall not become effective or enforceable until the revocation period has expired without my having exercised this right of revocation. 

  

	 	e)	 I have carefully read and fully understands all provisions of this Release, which includes a full release and
waiver of any and all claims. 

  

	 	f)	 I have signed this Release knowingly and voluntarily and understand that I am not waiving or releasing any
Claims that may arise after the date this waiver and release is executed. 

  

					
	Dated:                     	 	                                	 	  

		 		 	Kevin Olsen
			
	Dated:                     	 		 	  

		 		 	Witness
			
		 		 	  

		 		 	Print Witness Name

  
 3Exhibit

RESTRICTIVE COVENANTS AND GENERAL RELEASE AGREEMENT
THIS RESTRICTIVE COVENANTS AND GENERAL RELEASE AGREEMENT (the “Agreement”) is entered into on January 8, 2019 between Michael H. Michalak (hereafter “Executive”) and Comerica Incorporated, a Delaware corporation, for the benefit of Comerica Incorporated, Comerica Bank, a Texas banking association, all of their past, present and future subsidiaries, affiliates, predecessors, and successors, and all of their subsidiaries and affiliates, (hereafter all individually and collectively referred to as “Comerica”). This Agreement sets forth the complete understanding and agreement between Comerica and Executive relating to Executive’s employment and cessation of employment with Comerica.  This Agreement shall be effective as of the Effective Date (as defined in Paragraph 18 below), and in the event the Effective Date does not occur, this Agreement shall be void ab initio.
Accordingly, Executive and Comerica hereby agree as follows:
		
	1.
	Separation from Employment.  Executive and Comerica agree that Executive’s employment with Comerica shall terminate effective January 31, 2019 (the “Separation Date”).  

		
	2.
	Public Announcement.  Comerica may, in its sole discretion, issue one or more announcement(s) of Executive’s departure from Comerica at such time(s) as Comerica deems appropriate.

		
	3.
	Resignation from Boards and Committees.  Effective before or as of the Separation Date, Executive shall resign from any and all positions Executive holds as an officer, member or manager of Comerica and any and all positions Executive holds as a member of a Comerica board or committee.  

Restrictive Covenants and General Release Agreement    1 of 21

		
	4.
	Return of Comerica Property.  Executive shall return to Comerica, no later than the close of business on the Separation Date, all property of Comerica including, but not limited to, customer information, personal computer, laptop, keys, identification cards, access cards, corporate credit cards, and files or other documents received, compiled or generated by or for Executive in connection with or by virtue of Executive’s employment with Comerica.  

		
	5.
	Compensation and Benefits.  In consideration for the release of claims set forth in Paragraph 6, the covenants set forth in Paragraphs 7, 8, 9, 10 and 11 and such other promises of Executive as set forth in this Agreement, Comerica agrees that it shall pay or provide to Executive the following payments, benefits and/or other consideration:

		
	a.
	Prior to the Separation Date, so long as Executive continues to be employed by Comerica, Comerica shall continue to pay Executive’s regular base salary at the rate in effect as of immediately prior to the delivery of this Agreement, in accordance with the payroll practices of Comerica applicable to similarly situated executives. 

		
	b.
	Prior to the Separation Date, so long as Executive continues to be employed by Comerica, Executive shall continue to be eligible to participate in Comerica’s health, welfare benefit and retirement plans in which Executive participated immediately prior to the delivery of this Agreement, as such plans may be in effect from time to time.

		
	c.
	Following the Separation Date, Executive shall be eligible to elect continuation coverage under Comerica’s healthcare benefit plans in 

Restrictive Covenants and General Release Agreement    2 of 21

accordance with Section 4980B (“COBRA”) of the Internal Revenue Code of 1986, as amended (the “Code”), and the terms of the applicable plan.  Executive must elect COBRA and complete all COBRA documentation within sixty (60) days from the Separation Date for coverage to take effect.  
Assuming Executive elects COBRA continuation coverage under Comerica’s medical benefit plan, Executive shall be eligible to continue medical benefit plan coverage under COBRA for the period of coverage under COBRA, with the cost of such coverage to be paid by Executive pursuant to the terms generally applicable to retired employees of Comerica as in effect from time to time.  Executive’s conversion rights under other insurance programs following the Separation Date shall be determined in accordance with the terms of the applicable plan.
		
	d.
	Comerica shall reimburse Executive for reasonable and documented business expenses incurred by Executive on or before the Separation Date, in accordance with the terms of Comerica’s policy in effect as of the Separation Date.  

		
	e.
	Executive shall receive a lump-sum payment for all accrued but unused Paid Time Off (PTO) days that are paid upon termination of employment in accordance with the established policies of Comerica. This lump sum payment shall be subject to all applicable taxes, FICA, and other withholdings and deductions required by law.

		
	f.
	Executive will receive, pursuant to the terms of the 1999 Comerica Incorporated Amended and Restated Deferred Compensation Plan (“DCP”) 

Restrictive Covenants and General Release Agreement    3 of 21

and the 1999 Comerica Incorporated Amended and Restated Common Stock Deferred Incentive Award Plan (“DIAP”), distributions from Executive’s accounts, if any, under those plans, payable in accordance with Executive’s prior elections, the terms of the DCP and the DIAP, and applicable laws including, but not limited to, Section 409A of the Code.  Such distributions will be subject to all applicable taxes, FICA and other withholding and deductions required by law and will be made pursuant to the distribution schedule followed under the administrative procedures of the DCP and the DIAP, and applicable laws including, but not limited to, Section 409A of the Code.
		
	g.
	Stock options and/or performance-based restricted stock units granted to Executive under the Comerica Incorporated 2006 Amended and Restated Long-Term Incentive Plan or under the Comerica Incorporated 2018 Long-Term Incentive Plan, each as amended and/or restated from time to time (collectively, the “LT Incentive Plan”), shall be governed by the terms of the LT Incentive Plan and the respective grant agreements evidencing the grant of such options and/or restricted stock units.

		
	h.
	Executive received or will receive any and all applicable incentive payments to which he is entitled pursuant to the Comerica Incorporated 2016 Management Incentive Plan or its successor plan ("MIP") for performance periods ending on or prior to December 31, 2018, including, without limitation, incentive payments payable in the year 2019 based on the attainment of performance goals established by the Governance, 

Restrictive Covenants and General Release Agreement    4 of 21

Compensation and Nominating Committee under the MIP with respect to the one-year Annual Executive Incentive program with a performance period ending December 31, 2018. The amount of the payment(s), if any, was/were or will be made pursuant to the applicable funding formula and other criteria established by the Governance, Compensation and Nominating Committee, in accordance with the terms of the MIP, and is/are subject to all applicable taxes, FICA and other withholdings and deductions required by law.  Executive is not eligible for any additional incentive payment (prorated or otherwise) under the MIP, including, without limitation, any such incentive payment for performance periods ending December 31, 2019 or thereafter.    
		
	i.
	At the meeting of the Comerica Incorporated Governance, Compensation and Nominating Committee (the “Committee”) held or to be held on January 22, 2019, Comerica recommended or will recommend to the Committee that Executive’s restricted shares of Comerica Incorporated common stock that are not vested as of the Separation Date shall fully vest as of the Separation Date, subject to the execution and delivery by Executive of this Agreement at least eight (8) calendar days prior to the Separation Date and Executive’s non-revocation of this Agreement and subject to such other terms and conditions of the LT Incentive Plan and the grant agreements evidencing the grant of such restricted stock, including Executive’s obligation to satisfy all tax withholding obligations.

		
	j.
	To the extent provided by the Amended and Restated Bylaws of Comerica Incorporated, Article V, Section 12, Comerica agrees to defend, indemnify 

Restrictive Covenants and General Release Agreement    5 of 21

and hold Executive harmless from and against all liability for actions taken by Executive within the scope of Executive’s responsibilities so long as Executive’s conduct in any such matter was consistent with the standards contained in such Article V, Section12.
		
	6.
	Release of Claims.  In consideration for the payments and other benefits provided to Executive by this Agreement, including those described above in Paragraph 5, certain of which Executive is not otherwise entitled, and the sufficiency of which Executive acknowledges, Executive further agrees, as follows:

		
	a.
	For Executive and for all people acting on Executive’s behalf (such as, but not limited to, family, heirs, executors, administrators, personal representatives, agents and/or legal representatives), Executive agrees to waive any and all claims or grievances which Executive may have against Comerica and Comerica’s past or present stockholders, directors, officers, trustees, agents, representatives, attorneys, employees, in their individual or representative capacities, and any and all employee benefit plans and their respective past, current and future trustees and administrators (hereafter, collectively, the “Released Parties”).  By Executive’s signature hereto, Executive, for himself and for all people acting on Executive’s behalf, forever and fully releases and discharges any and all of the Released Parties from any and all claims, causes of action, contracts, grievances, liabilities, debts, judgments, and demands, including but not limited to any claims for attorney fees, that Executive ever had, now has, or may have by reason of or arising in whole or in part out of any event, act or omission 

Restrictive Covenants and General Release Agreement    6 of 21

occurring on or prior to the Effective Date of this Agreement.  This release includes, but is not limited to, any and all claims of any nature that relate to Executive’s employment by or termination of employment with Comerica.  This release includes, but is not limited to: claims of promissory estoppel, forced resignation, constructive discharge, libel, slander, deprivation of due process, wrongful or retaliatory discharge, discharge in violation of public policy, breach of contract, breach of implied contract, infliction of emotional distress, detrimental reliance, invasion of privacy, negligence, malicious prosecution, false imprisonment, fraud, assault and battery, interference with contractual or other relationships, or any other claim under common law.  This release also specifically includes, but is not limited to: any and all claims under any federal, state, and/or local law, regulation, or order prohibiting discrimination, including the Age Discrimination in Employment Act, the Americans With Disabilities Act, Title VII of the Civil Rights Act of 1964, the Elliott-Larsen Civil Rights Act, or the Michigan Persons With Disabilities Civil Rights Act, the Michigan Wage & Fringe Benefit Act, together with any and all claims under the Fair Credit Reporting Act, the Uniform Services Employment and Reemployment Rights Act, the Employee Retirement Security Income Security Act, the Family Medical Leave Act, or any other federal, state, and or local law, regulation, or order relating to employment, as they all have been or may be amended.  It is Executive’s intent, by executing this 

Restrictive Covenants and General Release Agreement    7 of 21

Agreement, to release all claims as specified above to the maximum extent permitted by law, whether said claims are presently known or unknown.
		
	b.
	To the maximum extent permitted by law, Executive agrees that Executive has not filed, nor will Executive ever file, a lawsuit asserting any claims which are released by this Agreement.  

		
	c.
	Executive understands and agrees that, other than the payments and benefits expressly enumerated in this Agreement, Executive is not entitled to receive any other compensation, incentive, wage, vacation or other paid time off, leave, benefit or other payment from Comerica, other than any vested benefits to which Executive may be entitled under the Comerica Incorporated Preferred Savings Plan, the Supplemental Retirement Income Account Plan for Employees of Comerica Incorporated, the Comerica Incorporated Retirement Income Account Plan,  the DCP, the DCIAP, and the Comerica Incorporated Amended and Restated Employee Stock Purchase Plan, each as amended and/or restated from time to time, and in each case in accordance with the terms of such plans and, if applicable, any valid elections thereunder.  In addition, prior to November 23, 2004, a portion of the Executive’s incentive bonus attributable to the three-year performance period under the MIP’s predecessor plan(s) was automatically invested in common stock that is non-transferrable until Executive terminates employment with Comerica (sometimes referred to as the non-deferred 3-year award program) (the “Non-Deferred Account”).  Executive 

Restrictive Covenants and General Release Agreement    8 of 21

shall be entitled to receive the shares in Executive’s Non-Deferred Account following Executive’s Separation Date.
		
	d.
	The provisions of this Paragraph 6 do not apply to any claim Executive may have for representation and indemnification pursuant to Paragraph 5(j) above. 

		
	7.
	Disclosure of Information.  Executive hereby acknowledges that Executive has been and will continue to have access and exposure to confidential and proprietary information of Comerica and trade secrets, including details of the business or affairs of Comerica, its subsidiaries or affiliates (including, without limitation, planning information and strategies, information and/or strategies for the prosecution and/or defense of any matter that is now or may be in the future the subject of any lawsuit, dispute, controversy, claim and/or regulatory action, financial information, organizational structure, strategic planning, sales and marketing strategies, distribution methods, data processing and other systems, personnel policies and compensation plans and arrangements); any customer or advertising lists; any information, knowledge or data of a technical nature (including, without limitation, methods, know-how, processes, discoveries, machines, or research projects); any information, knowledge or data relating to future developments (including without limitation, tax planning research and development, future marketing or merchandising); or any and all other trade secrets (collectively, "Confidential Information").  Confidential Information does not include (i) information already known or independently developed by Executive from public sources or information in the public domain, (ii) information in the 

Restrictive Covenants and General Release Agreement    9 of 21

public domain through no wrongful act of the recipient, or (iii) information received by Executive from a third party who was free to disclose it.  Executive understands that Comerica’s Confidential Information, including its trade secrets, is highly sensitive information relating to the business of Comerica and of Comerica’s clients, which has had its secrecy protected both internally and externally and which is a competitive asset of Comerica.  Executive hereby agrees that Executive shall not use, commercialize or disclose such Confidential Information to any person or entity, except to such individuals as approved by Comerica in writing prior to any such disclosure or as otherwise required by law. Nothing in this Agreement shall prohibit or limit Executive’s ability to make disclosures that are protected by Rule 21F-17 of the Securities and Exchange Act of 1934 or similar provisions of federal law or regulation, including, without limitation, disclosures pursuant to Section 922 of the Dodd-Frank Wall Street Reform and Consumer Protection Act.  Executive’s obligations pursuant to this Paragraph shall survive the termination of this Agreement.
		
	8.
	Cooperation.  Executive agrees that in the event of a legal proceeding (whether threatened or pending, whether investigative, administrative, or judicial) involving matters of which Executive has knowledge by virtue of the positions Executive held during Executive’s employment at Comerica, Executive shall disclose to Comerica and its counsel any facts known to Executive which might be relevant to said legal proceeding and shall cooperate fully with Comerica and its counsel so as to enable Comerica to present any claim or defense which it may have relating to such matters.  For purposes of this paragraph, “cooperate fully” shall mean that 

Restrictive Covenants and General Release Agreement    10 of 21

Executive shall make himself reasonably available for interviews, depositions, and testimony as directed by Comerica or its counsel, and shall further execute truthful statements, declarations, or affidavits pertaining to such matters at the request of Comerica or its counsel.  Executive shall be reimbursed for any reasonable out of pocket expenses that Executive may incur as a result of Executive’s compliance with this Paragraph, subject to Comerica’s expense reimbursement policies.  Nothing in this Paragraph shall be construed as requiring Executive to be non-truthful or as preventing Executive from disclosing information that would be considered adverse to Comerica or requiring Executive to do anything in violation of any applicable law, rule or regulation.
		
	9.
	Non-Disparagement.  

		
	a.
	Executive agrees that Executive will make no disparaging remarks about Comerica, its parent and/or affiliates, their respective businesses, products or services, any current or former director, the Chairman and Chief Executive Officer, or any of Executive’s direct reports, or their policies, procedures or practices (including but not limited to, business, lending, or credit policies, procedures or practices) to any third parties, including but not limited to, customers or prospective customers of Comerica.  It is agreed and understood that nothing in this Paragraph 9(a) shall be construed to preclude Executive from (1) testifying truthfully pursuant to subpoena or as otherwise required by law, (2) engaging in any action consistent with public policy, or (3) cooperating in any internal or government investigation to the extent such cooperation is mandated by policy, regulation or statute.  

Restrictive Covenants and General Release Agreement    11 of 21

Executive agrees that Executive shall provide notice to Comerica in advance of any such cooperation or testimony, unless such notice is prohibited.  It is further understood that nothing in this Paragraph 9(a) shall be construed to preclude Executive from discharging Executive’s legal obligations to any administrative or regulatory agencies or auditing entities.
		
	b.
	Comerica agrees that the Chairman and Chief Executive Officer and his direct reports will not make any disparaging remarks regarding Executive or Executive’s performance while employed at Comerica. It is agreed and understood that nothing in this Paragraph 9(b) shall be construed to preclude those covered from (1) testifying truthfully pursuant to subpoena or as otherwise required by law, (2) engaging in any action consistent with public policy, or (3) cooperating in any internal or government investigation to the extent such cooperation is mandated by policy, regulation or statute.  It is further agreed and understood that nothing in this Paragraph shall be construed to preclude Comerica from discharging its legal obligations to its Boards of Directors, any administrative or regulatory agencies or auditing entities.

		
	10.
	Non-Competition and Non-Solicitation.  Prior to the Separation Date and for the period ending two (2) years after the execution of this Agreement, Executive agrees that Executive shall not, directly or indirectly, for Executive’s own account or in conjunction with any other person or entity, whether as an employee, shareholder, 

Restrictive Covenants and General Release Agreement    12 of 21

partner, investor, principal, agent, representative, proprietor, consultant, or in any other capacity, do any of the following:
		
	a.
	Enter into or engage in any business in competition with the businesses conducted by Comerica in the states of Michigan, California, Texas, Arizona

or Florida.  For purposes of this Paragraph 10(a), Executive shall be “in competition with Comerica” if (1) Executive accepts employment or serves as an agent, employee, director or consultant to, a competitor of Comerica, or (2) Executive acquires or has an interest (direct or indirect) in any firm, corporation, partnership or other entity engaged in a business that is competitive with Comerica.  The mere ownership of less than 1% debt and/or equity interest in a competing entity whose stock is publicly held shall not be considered as having a prohibited interest in a competitor, and neither shall the mere ownership of less than 5% debt and/or equity interest in a competing entity whose stock is not publicly held.  For purposes of this Paragraph 10(a), any commercial bank, savings and loan association, securities broker or dealer, or other business or financial institution that offers any major service offered by Comerica as of the Separation Date, and which conducts business in Michigan, California, Texas, Arizona or Florida, shall be deemed a competitor;
		
	b.
	Request or advise any individual or company that is a customer of Comerica to withdraw, curtail, or cancel any such customer’s actual or prospective business with Comerica;

Restrictive Covenants and General Release Agreement    13 of 21

		
	c.
	Solicit, induce or attempt to induce any customers of Comerica with whom Executive had professional contact or with respect to whom Executive was privy to any information during the two (2) year period prior to the 

Separation Date to patronize any business that is competitive with Comerica; and
		
	d.
	Solicit or induce or attempt to solicit or induce any employee, agent or consultant of Comerica to terminate his or her employment, representation, or other relationship with Comerica. 

During the two-year period following the execution of this Agreement, Executive may request an exception to this provision.  The request must be made in writing, describe the scope and nature of the engagement, and be directed to Comerica’s Chief Legal Officer.  Any exception will be at Comerica’s sole discretion.  
11.    Representation.  Executive represents and warrants:
		
	a.
	Executive has no knowledge of, is not otherwise aware of, has no evidence of and/or has not reported to any person, organization and/or governmental or regulatory authority any of the following: (i) any violation by the Released Parties of any securities and/or other laws, rules and regulations applicable to Comerica, (ii) any breach by Comerica and/or by any Released Party of any fiduciary duty or obligation to any person, organization and/or governmental or regulatory authority, and/or (iii) any violation by any Released Party of Comerica’s Code of Business Conduct and Ethics for Employees, Senior Financial Officer Code of Ethics, or Code of Business 

Restrictive Covenants and General Release Agreement    14 of 21

Conduct and Ethics for Members of the Board of Directors, each as amended and/or restated from time to time.
		
	b.
	Executive has a special relationship of trust and confidence with Comerica and its customers and clients, which creates a high risk and opportunity for 

Executive to misappropriate the relationship and goodwill existing between Comerica and such entities and individuals.  Executive further acknowledges that, at the outset of Executive’s employment with Comerica and throughout Executive’s employment with Comerica, Executive received, and continues to receive and/or have access to Comerica and Comerica’s clients’ proprietary Confidential Information, specialized training and goodwill that Executive would not otherwise have but for Executive’s employment with Comerica.  Therefore, Executive agrees that it is fair and reasonable for Comerica to take steps to protect itself from the risk of misappropriation of Comerica’s trade secrets including but not limited to its business relationships, goodwill, proprietary information, specialized training, and other Confidential Information.  
		
	c.
	Executive agrees Executive has carefully considered the nature and extent of the restrictions placed upon Executive and the remedies conferred upon Comerica in this Agreement and has had the opportunity to retain legal counsel at Executive’s own expense to review this Agreement.  Executive agrees the restrictions are reasonable in time and geographic scope and are necessary to protect the legitimate business interests of Comerica and its 

Restrictive Covenants and General Release Agreement    15 of 21

customers and do not confer a benefit on Comerica that is out of proportion to the restrictions placed on Executive.
12.    Dispute Resolution.
		
	a.
	Early Resolution Conference.  This Agreement is understood to be clear and enforceable as written and is executed by both parties on that basis.  

However, should Executive later challenge any provision as unclear, unenforceable, or inapplicable to any competitive or other activity that Executive intends to engage in, Executive will first notify Comerica in writing and meet with a Comerica representative and a neutral mediator (if either party elects to retain one at its own expense) to discuss resolution of any disputes between the parties.  Executive will provide this notification at least fourteen (14) calendar days before Executive engages in any activity that could reasonably and foreseeably fall within a questioned restriction.  Executive’s failure to comply with this early resolution conference requirement (the “Resolution Requirement”) shall waive Executive’s right to challenge the reasonable scope, clarity, applicability or enforceability of this Agreement and its restrictions at a later time.  Comerica will respond to Executive’s notification required by this Paragraph within fourteen (14) calendar days following receipt of the written notification.  Comerica’s failure to respond with an acceptance or denial within the fourteen (14) calendar day period, unless a party has invoked the mediation process described above, shall waive its right to challenge Executive’s activity that could reasonably fall within a questioned restriction at a later time.  All 

Restrictive Covenants and General Release Agreement    16 of 21

rights of both parties will be preserved if the Resolution Requirement is complied with even if no agreement is reached in the conference.
		
	b.
	Injunctive Relief.  In the event of a breach or threatened breach of Paragraphs 6, 7, 8, 9, 10, or 11 of this Agreement, Executive agrees that Comerica shall be entitled to injunctive relief in a Michigan court of appropriate jurisdiction to remedy any such breach or threatened breach, and Executive acknowledges that monetary damages alone would not be an adequate remedy to compensate Comerica for the loss of goodwill and other harm to its reputation and business.

		
	c.
	Arbitration.  Except as provided in Paragraph 12(a) and (b) hereof, in the event of any dispute between any of the Released Parties and Executive relating to Executive’s employment with or separation from employment with Comerica, the terms of and the parties’ entry into this Agreement and/or breach of this Agreement, Executive and Comerica agree to submit the dispute, including any claims of discrimination under federal, state or local law by Executive, to final and binding arbitration pursuant to the provisions of Michigan statutory law and/or the Federal Arbitration Act, 9 U.S.C. Sec. 1 et seq.  The arbitration shall be conducted by the National Center for Dispute Settlement or a similar organization mutually agreed to by the parties.  The arbitration shall be before a single, neutral arbitrator selected by the parties.  

In the event the parties cannot agree on the selection of a single arbitrator, the following process to select an arbitration panel will be followed:  (1)

Restrictive Covenants and General Release Agreement    17 of 21

when a party reasonably believes that there will be no agreement on the selection of a single, neutral arbitrator, that party may notify the other at the address provided in Paragraph 17 of this Agreement of the fact an impasse has been reached, (2) within five (5) days of receipt of such notice, each party must provide the other with the name of its respective panel member, and (3) within ten (10) days of their selection, the parties’ panel members must agree on the third, neutral member of the arbitration panel.
The arbitrator, or arbitration panel (“panel”) if one is utilized, shall have the power to enter any award that could be entered by a judge of a trial court of the State of Michigan, and only such power, and shall follow the law.  Notwithstanding the foregoing, the arbitrator or panel may award reasonable attorney fees and costs to the prevailing party.  In the event the arbitrator or panel does not follow the law, the arbitrator or panel will have exceeded the scope of his or her authority and the parties may, at their option, file a motion to vacate the award in court.  Except as otherwise provided herein, the parties agree to abide by and perform any award rendered by the arbitrator.  The arbitrator or panel shall issue the award in writing and therein state the essential findings and conclusions on which the award is based.  Judgment on the award may be entered in any court having jurisdiction thereof.  In no event shall the demand for arbitration be made after the date when institution of legal or equitable proceedings based on such claim, dispute or other matter in question would be barred by the applicable statute of limitations.  This agreement to arbitrate shall be 

Restrictive Covenants and General Release Agreement    18 of 21

specifically enforceable under the prevailing arbitration law, and shall be in accordance with the procedures established for arbitration in the Michigan Rules of Civil Procedure.  Unless otherwise prohibited by law, each party shall bear its own costs, including, but not limited to, any costs associated with the appointment of its panel member in the event an arbitration panel 
is constituted, in any such arbitration and shall share equally any fees or other expenses charged by the neutral arbitrator for services rendered.  The parties understand that by agreeing to arbitrate their disputes, they are giving up their right to have their disputes heard in a court of law and, if applicable, by a jury.
		
	13.
	Entire Agreement.  This Agreement supersedes all prior and contemporaneous relationships, agreements, understandings, negotiations and discussions, whether oral or written, of the parties with respect to the subject matter hereof, to the extent they conflict herewith, and, except as otherwise set forth herein, there are no other agreements between the parties with respect to the subject matter hereof.  No amendment, supplement, modification or waiver of this Agreement shall be implied or be binding unless in writing and signed by the party against which such amendment, supplement, modification or waiver is asserted.  No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar), nor shall such waiver constitute a continuing waiver, unless otherwise therein provided.

Restrictive Covenants and General Release Agreement    19 of 21

		
	14.
	Governing Law.  This Agreement shall be interpreted and governed by the laws of the State of Michigan, except as to matters specifically governed by federal statute or regulation.  

		
	15.
	Severability.    The provisions of this Agreement are severable, and if any part or portion of it is found to be unenforceable, the other portions shall remain fully valid and enforceable.

		
	16.
	Withholding.  Comerica may withhold from any amounts payable under this Agreement such Federal, state or local taxes as shall be required to be withheld pursuant to any applicable law or regulation.

		
	17.
	Notice.  Any notices relating to or arising out of this Agreement shall be sent by registered mail, return receipt requested, and shall be addressed as follows:

To Comerica:
John D. Buchanan, 
Executive Vice President, Chief Legal Officer  
1717 Main Street, MC 6504
Dallas, Texas 75201

To Executive:

Michael H. Michalak
At the address on record with Comerica as of the Separation Date   

		
	18.
	Consideration Period, Revocation Period and Effective Date.  Executive confirms that Executive had at least twenty-one (21) days to consider this Agreement, or that, by executing this Agreement, Executive voluntarily waives the twenty-one (21) day consideration period and that Executive had an opportunity to consult with an attorney during said consideration period and prior to signing this Agreement.  For an additional period of seven (7) days following the signing of this Agreement, 

Restrictive Covenants and General Release Agreement    20 of 21

Executive understands Executive may revoke Executive’s signature by delivery of a written notice of revocation to Von E. Hays, Senior Vice President and General Counsel, Litigation and Corporate Operations, 1717 Main Street, 4th Floor, MC 6506, Dallas, Texas, 75201.  The revocation must be delivered to this address before 5:00 p.m. CST on or before the 7th day following the signing of this Agreement.  This Agreement shall become effective and enforceable on the eighth (8th) day following its execution by Executive, provided Executive does not exercise Executive’s right of revocation as described above (the “Effective Date”). If Executive revokes Executive’s signature, this Agreement will be without force or effect, and Executive shall not be entitled to any of the rights and benefits hereunder.

Delivered to Executive for Executive’s consideration this 2nd day of January, 2019.

Comerica Incorporated 

		
	By:
	/s/ John D. Buchanan        

		
	Name:
	John D. Buchanan    

		
	Title:
	Executive Vice President, 

 Chief Legal Officer

		
	Date:   
	January 8, 2019        

I, MICHAEL H. MICHALAK, HAVING READ THE FOREGOING SEPARATION AND RESTRICTIVE COVENANTS AGREEMENT, UNDERSTANDING ITS CONTENT AND HAVING HAD AN OPPORTUNITY, AND BEEN ADVISED, TO CONSULT WITH COUNSEL OF MY CHOICE, DO HEREBY KNOWINGLY AND VOLUNTARILY SIGN THIS AGREEMENT, THEREBY AGREEING TO THE TERMS THEREOF AND WAIVING AND RELEASING MY CLAIMS, ON JANUARY 8, 2019.

 

/s/ Michael H. Michalak    
Michael H. Michalak

Restrictive Covenants and General Release Agreement    21 of 21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]